References
Wassef M, Blei F, Adams D, et al. Vascular Anomalies Classification: Recommendations from the International Society for the Study of Vascular Anomalies. Pediatrics 2015; 136: e203–14.
Brouillard P, Boon LM, Mulliken JB, et al. Mutations in a novel factor, glomulin, are responsible for glomuvenous malformations (“glomangiomas”). Am J Hum Genet 2002; 70: 866–74.
Conde–Taboada A, Campos L, Cuccolini L, López–Bran E. Multiple, neonatal, self–healing, cutaneous glomuvenous malformations. Indian J Dermatol Venereol Leprol 2017; 83: 226–8.
Vikkula M, Boon LM, Carraway KL III, et al. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell 1996; 87: 1181–90.
Soblet J, Limaye N, Uebelhoer M, Boon LM, Vikkula M. Variable somatic TIE2 mutations in half of sporadic venous malformations. Mol Syndromol 2013; 4: 179–83.
Soblet J, Kangas J, Nätynki M, et al. Blue rubber bleb nevus (BRBN) syndrome is caused by somatic TEK (TIE2) mutations. J Invest Dermatol 2017; 137: 207–16.
Brouillard P, Boon LM, Revencu N, et al. Genotypes and phenotypes of 162 families with a glomulin mutation. Mol Syndromol 2013; 4: 157–64.
Amyere M, Aerts V, Brouillard P, et al. Somatic uniparental isodisomy explains multifocality of glomuvenous malformations. Am J Hum Genet 2013; 92: 188–96.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Collantes-Rodríguez, C., De La Varga-Martínez, R., Ossorio-García, L. et al. Glomulin mutation and glomuvenous malformations: two case reports with the same mutation but different phenotypes. Eur J Dermatol 28, 716–718 (2018). https://doi.org/10.1684/ejd.2018.3390
Published:
Issue Date:
DOI: https://doi.org/10.1684/ejd.2018.3390